Abstract:Background: Doxorubicin (Dox) is one of the most effective chemotherapy agents used in the treatment of solid tumors and hematological malignancies. However, it causes dose-related cardiotoxicity that may lead to heart failure in patients. Luteolin (Lut) is a common flavonoid that exists in many types of plants. It has been studied for treating various diseases such as hypertension, inflammatory disorders, and cancer. In this study, we evaluated the cardioprotective and anticancer effects of Lut on Dox-induced cardiomyopathy in vitro and in vivo to explore related mechanisms in alleviating dynamin-related protein (Drp1)-mediated mitochondrial apoptosis.Methods: MTT and LDH assay were used to determine the viability and toxicity of cardiomyocytes treated with Dox and Lut. Flow cytometry was used to examine ROS levels, and electron and confocal microscopy was employed to assess the mitochondrial morphology. The level of apoptosis was examined by Hoechst 33258 staining. The protein levels of myocardial fission protein and apoptosis-related protein were examined using Western blot. Transcriptome analysis of the protective effect of Lut against Dox-induced cardiac toxicity in myocardial cells was performed using RNA sequencing technology. The protective effects of Lut against cardiotoxicity mediated by Dox in zebrafish were quantified. The effect of Lut increase the antitumor activity of Dox in breast cancer both in vitro and in vivo were further employed.Results: Lut ameliorated Dox-induced toxicity in H9c2 and AC16 cells. The level of oxidative stress was downregulated by Lut after Dox treatment of myocardial cells. Lut effectively reduced the increased mitochondrial fission post Dox stimulation in cardiomyocytes. Apoptosis, fission protein Drp1, and Ser616 phosphorylation were also increased post Dox and reduced by Lut. In the zebrafish model, Lut significantly preserved the ventricular function of zebrafish after Dox treatment. Moreover, in the mouse model, Lut prevented Dox-induced cardiotoxicity and enhanced the cytotoxicity in triple-negative breast cancer by inhibiting proliferation and metastasis and inducing apoptosis.

Protection of Luteolin-7-O-glucoside Against Apoptosis Induced by Hypoxia/reoxygenation Through the MAPK Pathways in H9c2 Cells.

Lycopene protects against apoptosis in hypoxia/reoxygenation‑induced H9C2 myocardioblast cells through increased autophagy.

Cardioprotective Effects of Luteolin on Ischemia/reperfusion Injury in Diabetic Rats Are Modulated by Enos and the Mitochondrial Permeability Transition Pathway.

Luteoloside attenuates anoxia/reoxygenation-induced cardiomyocytes injury via mitochondrial pathway mediated by 14-3-3η protein.

Protective Effects of Luteolin-7-o-glucoside Against Starvation-Induced Injury Through Upregulation of Autophagy in H9c2 Cells.

Protection of Luteolin-7-O-Glucoside Against Doxorubicin-Induced Injury Through Pten/Akt and Erk Pathway in H9c2 Cells

Hongjingtian Injection Attenuates Myocardial Oxidative Damage Via Promoting Autophagy and Inhibiting Apoptosis.

Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis

The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway

Luteoloside pretreatment attenuates anoxia-induced damage in cardiomyocytes by regulating autophagy mediated by 14-3-3 eta and the AMPK alpha-mTOR/ULK1 pathway

Luteolin Improves Myocardial Cell Glucolipid Metabolism by Inhibiting Hypoxia Inducible Factor-1Α Expression in Angiotensin II/hypoxia-induced Hypertrophic H9c2 Cells.

Luteoloside pretreatment attenuates anoxia-induced damage in cardiomyocytes by regulating autophagy mediated by 14-3-3η and the AMPKα-mTOR/ULK1 pathway

Effects of Luteolin on Two Types of Hypoxia /Reoxygenation Injury in H9c2 Cardiomyocytes

Troxerutin Regulates HIF‐1α by Activating JAK2/STAT3 Signaling to Inhibit Oxidative Stress, Inflammation, and Apoptosis of Cardiomyocytes Induced by H2O2

Protective Effect of Lycopene on Hypoxia/Reoxygenation Injury in Rat Cardiomyocytes and Its Mechanism

Luteolin Protects Cardiomyocytes Cells against Lipopolysaccharide-Induced Apoptosis and Inflammatory Damage by Modulating Nlrp3

Luteolin inhibits ROS-activated MAPK pathway in myocardial ischemia/reperfusion injury

ERK/PP1a/PLB/SERCA2a and JNK Pathways Are Involved in Luteolin-Mediated Protection of Rat Hearts and Cardiomyocytes following Ischemia/Reperfusion

Cardioprotection of Klotho Against Myocardial Infarction-Induced Heart Failure Through Inducing Autophagy.

Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer

Oxidative Stress Suppression by Luteolin-Induced Heme Oxygenase-1 Expression